Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05325216

Urinary Continence of Female POPRC and OIN

Urinary Continence of Female Pelvic Organ-preserving Radical Cystectomy and Orthotopic Ileal Neobladder: A Randomized Controlled Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
58 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
Female
Age
55 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To compare the urinary continence rate and long-term oncological outcomes of pelvic-organ preserving radical cystectomy (POPRC) with orthotopic ileal neobladder (OIN) versus standard radical cystectomy(SRC) with OIN.

Detailed description

Radical cystectomy is the gold standard for muscle-invasive bladder. Orthotopic ileal neobladder, as one of the urinary diversion methods, is preferred whenever possible to achieve a better postoperative quality of life. For standard radical cystectomy (SRC) in females, the uterus, fallopian tubes, ovaries, anterior vaginal wall, and regional lymph nodes undergo en bloc resection with the bladder and urethra . With regard to the wide range of resection, continence disorder and sexual dysfunction are very common after surgery. Pelvic-organ sparing radical cystectomy involves the preservation of the female vagina, uterus, neurovascular bundles, and any enhancement of the aforementioned techniques . Previous studies demonstrated that POPRC might not affect long-term survival and instead improve continence outcomes. However, most of the available studies are retrospective with limited cases in a single center. The current study primarily aims to urinary continence rate and long-term oncological outcomes of POPRC+OIN versus SRC+OIN in a prospective randomized controlled trial.

Conditions

Interventions

TypeNameDescription
PROCEDUREPOPRC+OINPelvic-organ preserving radical cystectomy with orthotopic ileal neobladder
PROCEDURESRC+OINStandard radical cystectomy with orthotopic ileal neobladder

Timeline

Start date
2022-04-01
Primary completion
2028-04-01
Completion
2028-04-01
First posted
2022-04-13
Last updated
2022-04-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05325216. Inclusion in this directory is not an endorsement.